These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 21964939)

  • 21. Serological response to Actinobacillus pleuropneumoniae serovar 7 infection in a commercial pig herd.
    Gardner IA; Bossé JT; Sheldrake RF; Rosendal S; Johnson RP
    Aust Vet J; 1991 Nov; 68(11):349-52. PubMed ID: 1776931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant ApxIV protein enhances protective efficacy against Actinobacillus pleuropneumoniae in mice and pigs.
    Wu HC; Yeh PH; Hsueh KJ; Yang WJ; Chu CY
    J Appl Microbiol; 2018 Jun; 124(6):1366-1376. PubMed ID: 29431246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An evaluation of the role of antibodies to Actinobacillus pleuropneumoniae serovar 1 and 15 in the protection provided by sub-unit and live streptomycin-dependent pleuropneumonia vaccines.
    Tumamao JQ; Bowles RE; van den Bosch H; Klaasen HL; Fenwick BW; Blackall PJ
    Aust Vet J; 2004 Dec; 82(12):773-80. PubMed ID: 15648941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interference of outer membrane protein PalA with protective immunity against Actinobacillus pleuropneumoniae infections in vaccinated pigs.
    van den Bosch H; Frey J
    Vaccine; 2003 Sep; 21(25-26):3601-7. PubMed ID: 12922088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Galactose-1-phosphate uridyltransferase (GalT), an in vivo-induced antigen of Actinobacillus pleuropneumoniae serovar 5b strain L20, provided immunoprotection against serovar 1 strain MS71.
    Zhang F; Zhao Q; Quan K; Zhu Z; Yang Y; Wen X; Chang YF; Huang X; Wu R; Wen Y; Yan Q; Huang Y; Ma X; Han X; Cao S
    PLoS One; 2018; 13(6):e0198207. PubMed ID: 29856812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation of Actinobacillus pleuropneumoniae serovar 15-like strain from a field case of porcine pleuropneumonia in Japan.
    Koyama T; To H; Nagai S
    J Vet Med Sci; 2007 Sep; 69(9):961-4. PubMed ID: 17917383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of serovar-independent ELISA antigens of Actinobacillus pleuropneumoniae in pigs, following experimental challenge with A. pleuropneumoniae, Mycoplasma hyopneumoniae and Pasteurella multocida.
    Eamens GJ; Gonsalves JR; Whittington AM; Turner B
    Aust Vet J; 2012 Jun; 90(6):225-34. PubMed ID: 22632286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a DIVA subunit vaccine against Actinobacillus pleuropneumoniae infection.
    Maas A; Meens J; Baltes N; Hennig-Pauka I; Gerlach GF
    Vaccine; 2006 Nov; 24(49-50):7226-37. PubMed ID: 17027123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental reproduction of acute lesions of porcine pleuropneumonia with a haemolysin-deficient mutant of Actinobacillus pleuropneumoniae.
    Rycroft AN; Williams D; McCandlish IA; Taylor DJ
    Vet Rec; 1991 Nov; 129(20):441-3. PubMed ID: 1781136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cloning, expression, and characterization of TonB2 from Actinobacillus pleuropneumoniae and potential use as an antigenic vaccine candidate and diagnostic marker.
    Liu J; Chen Y; Yuan F; Hu L; Bei W; Chen H
    Can J Vet Res; 2011 Jul; 75(3):183-90. PubMed ID: 22210994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attenuated Actinobacillus pleuropneumoniae double-deletion mutant S-8∆clpP/apxIIC confers protection against homologous or heterologous strain challenge.
    Xie F; Li G; Zhou L; Zhang Y; Cui N; Liu S; Wang C
    BMC Vet Res; 2017 Jan; 13(1):14. PubMed ID: 28061786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infection dynamics and acute phase response of an Actinobacillus pleuropneumoniae field isolate of moderate virulence in pigs.
    Gómez-Laguna J; Islas A; Muñoz D; Ruiz A; Villamil A; Carrasco L; Quezada M
    Vet Microbiol; 2014 Oct; 173(3-4):332-9. PubMed ID: 25201629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk assessment of transmission of capsule-deficient, recombinant Actinobacillus pleuropneumoniae.
    Inzana TJ; Glindemann G; Fenwick B; Longstreth J; Ward D
    Vet Microbiol; 2004 Nov; 104(1-2):63-71. PubMed ID: 15530740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of serology, bacteriological isolation and polymerase chain reaction for the detection of pigs carrying Actinobacillus pleuropneumoniae in the upper respiratory tract after experimental infection.
    Chiers K; Donné E; Van Overbeke I; Ducatelle R; Haesebrouck F
    Vet Microbiol; 2002 Sep; 88(4):385-92. PubMed ID: 12220813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of an enzyme-linked immunosorbent assay for detection of antibodies to Actinobacillus pleuropneumoniae serovar 15 in pig sera.
    Teshima K; Lee J; To H; Kamada T; Tazumi A; Hirano H; Maruyama M; Ogawa T; Nagai S; Turni C; Tsutsumi N
    J Vet Med Sci; 2017 Dec; 79(12):1968-1972. PubMed ID: 29070770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation and characterization of atypical Actinobacillus pleuropneumoniae serovar 15 lacking the apxIICA genes in Japan.
    Teshima K; Hirano H; Ushiyama K; Shibuya K; Nagai S; Sasakawa C; To H
    J Vet Med Sci; 2019 Mar; 81(3):480-485. PubMed ID: 30713216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptional profiling of Actinobacillus pleuropneumoniae during the acute phase of a natural infection in pigs.
    Deslandes V; Denicourt M; Girard C; Harel J; Nash JH; Jacques M
    BMC Genomics; 2010 Feb; 11():98. PubMed ID: 20141640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the protective efficacy of Actinobacillus pleuropneumoniae serotype 1 detoxified lipopolysaccharides or O-polysaccharide-protein conjugate in pigs.
    Rioux S; Girard C; Dubreuil JD; Jacques M
    Res Vet Sci; 1998; 65(2):165-7. PubMed ID: 9839897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nasal immunization with major epitope-containing ApxIIA toxin fragment induces protective immunity against challenge infection with Actinobacillus pleuropneumoniae in a murine model.
    Seo KW; Kim SH; Park J; Son Y; Yoo HS; Lee KY; Jang YS
    Vet Immunol Immunopathol; 2013 Jan; 151(1-2):102-12. PubMed ID: 23200821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective efficacy of an affinity-purified hemolysin vaccine against experimental swine pleuropneumonia.
    Haga Y; Ogino S; Ohashi S; Ajito T; Hashimoto K; Sawada T
    J Vet Med Sci; 1997 Feb; 59(2):115-20. PubMed ID: 9070983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.